Holen Sie sich die Stockscreener-App
8.2063
1.38%
-0.1537
Schlusskurs vom Vortag:
$8.36
Offen:
$8.3
24-Stunden-Volumen:
597.87K
Relative Volume:
0.15
Marktkapitalisierung:
$368.85M
Einnahmen:
$123.87M
Nettoeinkommen (Verlust:
$62.49M
KGV:
4.9154
EPS:
1.6695
Netto-Cashflow:
$-87.53M
1W Leistung:
-0.19%
1M Leistung:
+37.87%
6M Leistung:
+145.38%
1J Leistung:
+78.07%
1-Tages-Spanne:
$8.03
$8.40
1-Wochen-Bereich:
$7.31
$8.50
52-Wochen-Spanne:
$2.71
$8.85
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
8.195 | 337.12M | 123.87M | 62.49M | -87.53M | 1.6695 |
VRTX
Vertex Pharmaceuticals Inc
|
549.30 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
818.17 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,046.88 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
147.70 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
213.26 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Agenus Inc (AGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
AGEN Stock TUESDAY MADNESS! (news Update) Agenus Stock Analysis Best Broker Review Challenge Cup Final 2026 (5MyfQl06Kh) - Mshale
Agenus Inc. (AGEN) Latest Stock News & Headlines - Yahoo Finance
Agenus extends $24.75 million loan maturity, adjusts payment terms with Ocean 1181 - Investing.com
Form 8K Agenus Inc For: 18 August By Investing.com - Investing.com South Africa
Agenus Extends $24.75M Term Loan to 2029 at 13% With Ocean 1181; Partly Payable in Stock - TradingView
Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock - Stock Titan
AGEN Q2 2026 Earnings: EPS Misses Estimates by 119.61% as Shares Slide 2.32%EBITDA Estimate Trend - Vinanet
Agenus Inc.AGEN Stock Chart Technical Analysis For 05-07-18 Monday Night Raw (hiEG5bsL6M) - Mshale
AGENUS INC SEC Filing (Aug 17, 2026) - Stock Titan
Agenus Puts Its BOT+BAL Cancer Combo To The Test - Finimize
Renaissance Technologies LLC Sells 257,900 Shares of Agenus Inc. $AGEN - MarketBeat
HC Wainwright Estimates Agenus' Q3 Earnings (NASDAQ:AGEN) - MarketBeat
Bold Move By Agenus: Cutting Costs By 60% To Focus On Groundbreaking Cancer Treatments Nikoloz Basilashvili (41VwNJliWR) - Mshale
Agenus grants CEO Garo Armen 1,971,500 performance-based stock options at $7.78 per share - Bitget
Agenus (NASDAQ: AGEN) awards 1.97M performance-tied stock options to CEO - Stock Titan
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL S - The National Law Review
Form 8K Agenus Inc For: 11 August By Investing.com - Investing.com South Africa
Agenus appoints Marco Tullio Marcucci to board of directors By Investing.com - Investing.com Nigeria
Agenus appoints Marco Tullio Marcucci to board of directors - Investing.com
Agenus Director Brian Corvese Granted 100,000 Stock Options Under 2019 Equity Incentive Plan - Kalkine Media
Agenus Director Thomas L. Harrison Granted 50,000 Stock Options Under 2019 Equity Incentive Plan - Kalkine Media
AGENUS appoints Marco Tullio Marcucci to its Board as Class II director - TradingView
Agenus Inc. (AGEN) expands board, appoints Marco Tullio Marcucci as Class II director - Stock Titan
Agenus Inc (AGEN) awards 50,000 stock options to director Thomas L. Harrison - Stock Titan
Agenus (AGEN) director Brian Corvese receives 100,000 stock options at $7.78 - Stock Titan
Wainwright cuts Agenus stock price target to $25 on higher costs - Investing.com Nigeria
Wainwright cuts Agenus stock price target to $25 on higher costs By Investing.com - Investing.com India
HC Wainwright Issues Positive Outlook for Agenus Earnings - MarketBeat
AGEN Stock (Agenus Stock) AGEN STOCK Analysis AGEN STOCK PREDICTION In AGEN Stock News Today Bella Vaughn Hunter Johnson Engagement (u90ZBraz9y) - Mshale
Why Agenus (AGEN Stock) Just Rocketed Up—Buy Now Or Too Late? Cigarette (l3DDhgoK4D) - Mshale
Agenus Inc (AGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agenus (AGEN) Stock Drops As One Off Gain Masks Profit Slip - Sahm
Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Agenus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Agenus Files for Resale of Up to 78 Million Shares - marketscreener.com
Agenus: Q2 Earnings Snapshot - Yahoo Finance
AGENUS INC Q2 2026: Revenue $34.5M, EPS $0.96— 10-Q Summary - TradingView
Agenus (NASDAQ: AGEN) raises $85M and books Zydus gain but flags going concern risk - Stock Titan
Agenus Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Agenus (NASDAQ: AGEN) files S-3 for 77.9M share resale and warrant cash - Stock Titan
Agenus Inc. (AGEN) awards 50,000 stock options to director Wright - Stock Titan
AGENUS INC (AGEN) awards 100,000 stock options to its CMO - stocktitan.net
Agenus Inc (AGEN) Stock News Today - TradingKey
Agenus Inc. (AGEN) grants director 50,000 stock options at $7.78 - Stock Titan
Agenus (AGEN) awards 200,000 stock options to executive chair Jennifer Buell - Stock Titan
Agenus Advances BOT+BAL in Neoadjuvant MSS Colon Cancer Through Phase 3 ROBBIN Trial - Oncodaily
Agenus reports Q2 results, plans phase 3 colon cancer trial - Investing.com
Agenus reports Q2 results, plans phase 3 colon cancer trial By Investing.com - Investing.com Nigeria
Is Agenus Inc (AGEN) Overvalued After Q2 Earnings Beat? Q2 EPS: $0.06, Revenue: $34.5M; GF Score: 40/100 - GuruFocus
Form 8K Agenus Inc For: 6 August By Investing.com - Investing.com Canada
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.16%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):